Press release

Despite the changing methods to achieve media coverage, the press

release remains the centre of any PR campaign. A well written and
targeted press release will attract media attention to your campaign
Guidance and help you to gain editorial, non-paid for media coverage.
Please ensure that all press releases are reviewed locally before use,
especially in countries where Neurobion Forte is a prescription product.

New observational, non-interventional clinical study -

a giant leap for taking care of peripheral neuropathy sufferers
Clinical study shows benefits on symptoms of peripheral neuropathy

Darmstadt, Germany, Jan 2018 - Peripheral neuropathy sufferers treated with a combination of three neurotropic
B vitamins, the active ingredients of Neurobion have experienced improvement on all neuropathy symptoms observed
in the study, independently from the cause of their neuropathy.

NERVES SENSORY
MOTOR
The nervous system allows us to perceive, comprehend, and respond
to the world around us. It coordinates voluntary actions like walking
and involuntary actions like breathing and swallowing. Nerves, the
components of the nervous tissue, enable impulses of sensation and
motion between the brain, spinal cord and other parts of the body.

PERIPHERAL NEUROPATHY

as tingling, increased or decreased sensitivity to vibration, hot or cold, numbness, muscle weakness and even burning
pain. Peripheral Neuropathy can cause “typical symptoms“ which appear more often and “atypical“ symptoms, which
are less frequent and can be overlooked or misinterpreted.
Example of symptoms of Peripheral Neuropathy:

Paresthesia Numbness Burning pain Sharp pain

Symptoms of peripheral neuropathy can seem innocuous but have an impact of the patients’ well-being and their

OBSERVATIONAL, NON-INTERVENTIONAL CLINICAL STUDY CONFIRMS THE BENEFITS

OF A UNIQUE TREATMENT FOR ALL
A new clinical study (Asian Journal of Medical Sciences, Jan 2018) has brought a major step forward for nerve

regardless of the cause of peripheral neuropathy.

itching, often felt in the arms and feet), they experienced relief on all these symptoms. It was also observed that the
longer they used the treatment, the more relief the patients felt from these symptoms.
Finally it is also very reassuring to see that the treatment has shown a good tolerance profile over
the whole duration (3 months).
QUICK FACTS AND SUMMARY
Causes and risk factors of peripheral neuropathy are multiple and include conditions such as:

nutritional deficiencies e.g. vitamin B deficiency…. and other unexplained causes1.

Neurobion Forte treatment:

disease. The symptoms were even more reduced over longer duration of treatment (for a 3 months period tested) and
the treatment was well tolerated.

MORE INFORMATION ABOUT NEUROBION

• Neurobion, the nerve care expert from Merck Consumer Health has been first launched in Austria in 1962 and
is now a world leader in neurotropic B vitamins combination products.
• Neurotropic B vitamins are vitamins exerting their benefits on the health of nervous system. They have an

health or peripheral neuropathy

• Neurobion is available on prescription/OTC (adapt based on country).

ABOUT MERCK’S CONSUMER HEALTH BUSINESS

The Consumer Health business of Merck aims at preparing society for a new era of humans living 100 healthy years. For this
purpose, the business supports the so-called WE100®
accordingly. The leading “lovebrands” of Merck’s Consumer Health business, such as Neurobion®, Bion®, Nasivin®, Seven Seas®,
Dolo-Neurobion®, and Femibion® support this overarching purpose through consumer-inspired innovation.
The Consumer Health business is with over 3,800 employees globally active in over 40 markets. The portfolio comprises of brands
with annual total sales of about $ 1 billion. Consumer Health is a business of the Healthcare business sector within the Merck
Group with global headquarters in Darmstadt, Germany. For more information please go to www.merck-consumer-health.com or
https://twitter.com/merck_ch.

ABOUT MERCK GROUP

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000
employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer
or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD
televisions. In 2016, Merck generated sales of € 15 billion in 66 countries.
Founded in 1668, Merck is the world’s oldest pharmaceutical and chemical company. The founding family remains the majority
owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are
the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

1 Head 2006